FDA Approved: RALOXIFENE HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approves Glenmark's original application for raloxifene hydrochloride (generic) for postmenopausal osteoporosis and for reducing the risk of invasive breast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer Risk Reduction in Postmenopausal Women At Risk
• Postmenopausal Osteoporosis

Drugs mentioned

• RALOXIFENE HYDROCHLORIDE (RALOXIFENE HYDROCHLORIDE)

Snippet

ORIG AP for RALOXIFENE HYDROCHLORIDE (RALOXIFENE HYDROCHLORIDE)